Overview

Comparative Bioavailability Study of Lisinopril Tablets, 10 mg

Status:
Completed
Trial end date:
1999-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the bioavailability of Par Lisinopril 10 mg Tablets and IPR Pharmaceuticals, Inc. Zestril (R).
Phase:
Phase 1
Details
Lead Sponsor:
Par Pharmaceutical, Inc.
Collaborator:
PharmaKinetics Laboratories Inc.
Treatments:
Lisinopril